Huangqi Shengmai Decoction alleviates right ventricular hypertrophy in hypoxic pulmonary hypertension via the Src/ERK1/2 signaling pathway.
Hypoxic pulmonary hypertension (HPH) often leads to right ventricular hypertrophy (RVH), a condition with limited therapeutic options. This study investigated the protective effects and mechanisms of Huangqi Shengmai Decoction (HSD) against HPH-induced RVH via network pharmacology combined with experimental validation....